Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 160

1.

PET-CT Surveillance versus Neck Dissection in Advanced Head and Neck Cancer.

Mehanna H, Wong WL, McConkey CC, Rahman JK, Robinson M, Hartley AG, Nutting C, Powell N, Al-Booz H, Robinson M, Junor E, Rizwanullah M, von Zeidler SV, Wieshmann H, Hulme C, Smith AF, Hall P, Dunn J; PET-NECK Trial Management Group.

N Engl J Med. 2016 Apr 14;374(15):1444-54. doi: 10.1056/NEJMoa1514493. Epub 2016 Mar 23.

2.

PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography-computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer.

Mehanna H, McConkey CC, Rahman JK, Wong WL, Smith AF, Nutting C, Hartley AG, Hall P, Hulme C, Patel DK, Zeidler SV, Robinson M, Sanghera B, Fresco L, Dunn JA.

Health Technol Assess. 2017 Apr;21(17):1-122. doi: 10.3310/hta21170.

3.

Revisiting the role of positron-emission tomography/computed tomography in determining the need for planned neck dissection following chemoradiation for advanced head and neck cancer.

Gourin CG, Boyce BJ, Williams HT, Herdman AV, Bilodeau PA, Coleman TA.

Laryngoscope. 2009 Nov;119(11):2150-5. doi: 10.1002/lary.20523.

PMID:
19544378
4.

Economic analysis of FDG-PET-guided management of the neck after primary chemoradiotherapy for node-positive head and neck squamous cell carcinoma.

Pryor DI, Porceddu SV, Scuffham PA, Whitty JA, Thomas PA, Burmeister BH.

Head Neck. 2013 Sep;35(9):1287-94. doi: 10.1002/hed.23108. Epub 2012 Sep 18.

PMID:
22987817
5.

N2 disease in patients with head and neck squamous cell cancer treated with chemoradiotherapy: is there a role for posttreatment neck dissection?

Cho AH, Shah S, Ampil F, Bhartur S, Nathan CO.

Arch Otolaryngol Head Neck Surg. 2009 Nov;135(11):1112-8. doi: 10.1001/archoto.2009.148.

PMID:
19917924
6.

Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.

Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome M, Carroll MA.

Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-40.

PMID:
17515501
7.

Deferring planned neck dissection following chemoradiation for stage IV head and neck cancer: the utility of PET-CT.

Nayak JV, Walvekar RR, Andrade RS, Daamen N, Lai SY, Argiris A, Smith RP, Heron DE, Ferris RL, Johnson JT, Branstetter BF 4th.

Laryngoscope. 2007 Dec;117(12):2129-34.

PMID:
17921898
8.

Neck dissection can be avoided after sequential chemoradiotherapy and negative post-treatment positron emission tomography-computed tomography in N2 head and neck squamous cell carcinoma.

Loo SW, Geropantas K, Beadsmoore C, Montgomery PQ, Martin WM, Roques TW.

Clin Oncol (R Coll Radiol). 2011 Oct;23(8):512-7. doi: 10.1016/j.clon.2011.03.008. Epub 2011 Apr 17.

PMID:
21501953
9.

Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.

Frank DK, Hu KS, Culliney BE, Persky MS, Nussbaum M, Schantz SP, Malamud SC, Holliday RA, Khorsandi AS, Sessions RB, Harrison LB.

Laryngoscope. 2005 Jun;115(6):1015-20.

PMID:
15933512
10.

Interim FDG PET/CT for predicting the outcome in patients with head and neck cancer.

Chen SW, Hsieh TC, Yen KY, Yang SN, Wang YC, Chien CR, Liang JA, Kao CH.

Laryngoscope. 2014 Dec;124(12):2732-8. doi: 10.1002/lary.24826. Epub 2014 Jul 10.

PMID:
25042474
11.

Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.

Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.

Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1418-23.

PMID:
15050318
12.

Utility of positron emission tomography-computed tomography in identification of residual nodal disease after chemoradiation for advanced head and neck cancer.

Gourin CG, Williams HT, Seabolt WN, Herdman AV, Howington JW, Terris DJ.

Laryngoscope. 2006 May;116(5):705-10.

PMID:
16652075
13.

The role of positron emission tomography scans in the management of the N-positive neck in head and neck squamous cell carcinoma after chemoradiotherapy.

Brkovich VS, Miller FR, Karnad AB, Hussey DH, McGuff HS, Otto RA.

Laryngoscope. 2006 Jun;116(6):855-8.

PMID:
16735902
14.

Planned neck dissection after chemoradiotherapy in advanced oropharyngeal squamous cell cancer: the role of US, MRI and FDG-PET/TC scans to assess residual neck disease.

Pellini R, Manciocco V, Turri-Zanoni M, Vidiri A, Sanguineti G, Marucci L, Sciuto R, Covello R, Sperduti I, Kayal R, Anelli V, Pichi B, Mercante G, Spriano G.

J Craniomaxillofac Surg. 2014 Dec;42(8):1834-9. doi: 10.1016/j.jcms.2014.06.023. Epub 2014 Jul 9.

PMID:
25150165
15.

Planned neck dissection before combined chemoradiation in organ preservation protocol for N2-N3 of supraglottic or hypopharyngeal carcinoma.

Liu XK, Li Q, Zhang Q, Su Y, Shi YX, Li H, Zeng ZY, Guo ZM.

ORL J Otorhinolaryngol Relat Spec. 2012;74(2):64-9. doi: 10.1159/000333111. Epub 2012 Feb 9.

PMID:
22327028
16.

Response evaluation after chemoradiotherapy for advanced nodal disease in head and neck cancer using diffusion-weighted MRI and 18F-FDG-PET-CT.

Schouten CS, de Graaf P, Alberts FM, Hoekstra OS, Comans EF, Bloemena E, Witte BI, Sanchez E, Leemans CR, Castelijns JA, de Bree R.

Oral Oncol. 2015 May;51(5):541-7. doi: 10.1016/j.oraloncology.2015.01.017. Epub 2015 Feb 26.

PMID:
25725587
17.
18.

Observation versus neck dissection for positron-emission tomography-negative lymphadenopathy after chemoradiotherapy.

Khodayari B, Daly ME, Bobinski M, Farwell DG, Shelton DK, Chen AM.

Laryngoscope. 2014 Apr;124(4):902-6. doi: 10.1002/lary.24411. Epub 2013 Oct 22.

PMID:
24115118
19.

A cost-effectiveness analysis of positron emission tomography-computed tomography surveillance versus up-front neck dissection for management of the neck for N2 disease after chemoradiotherapy.

Rabalais A, Walvekar RR, Johnson JT, Smith KJ.

Laryngoscope. 2012 Feb;122(2):311-4. doi: 10.1002/lary.22464. Epub 2012 Jan 17.

PMID:
22252963
20.

Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography After Concurrent Chemoradiotherapy in Locally Advanced Head-and-Neck Squamous Cell Cancer: The ECLYPS Study.

Van den Wyngaert T, Helsen N, Carp L, Hakim S, Martens MJ, Hutsebaut I, Debruyne PR, Maes ALM, van Dinther J, Van Laer CG, Hoekstra OS, De Bree R, Meersschout SAE, Lenssen O, Vermorken JB, Van den Weyngaert D, Stroobants S; ECLYPS investigators.

J Clin Oncol. 2017 Oct 20;35(30):3458-3464. doi: 10.1200/JCO.2017.73.5845. Epub 2017 Aug 30.

PMID:
28854069

Supplemental Content

Support Center